Biospecifics Technologies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.11.20	Endo Says HSR Waiting Period For BioSpecifics Tender Offer Expires - Quick Facts (RTTNews)
20.10.20	ABBV Seeks Expanded Approval Of Rinvoq, APTX Cheered By PTSD Data, ENDP Snaps Up BSTC, LQDA On Watch (RTTNews)
19.10.20	BioSpecifics Agrees To Be Acquired By Endo For Equity Value Of About $658.0 Mln (RTTNews)
09.05.18	BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results (PR Newswire)
14.03.18	BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
13.03.18	FDA Places Clinical Hold On ADXS Study, ALT Proves A Good Shot, RYTM On Track (RTTNews)
12.03.18	BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for... (PR Newswire)
22.01.18	BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference (PR Newswire)
10.11.17	BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results (PR Newswire)
07.11.17	BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference (PR Newswire)
20.09.17	BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
05.09.17	BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences (PR Newswire)
25.08.17	AllianceBernstein Global High Income Fund, Inc. Reports First Quarter Earnings (PR Newswire)
09.08.17	BioSpecifics Technologies Corp. Reports Second Quarter 2017 Financial Results (PR Newswire)
09.08.17	HealthWell Foundation Launches Fund to Provide Financial Assistance to People Living with Macular Degeneration (PR Newswire)
02.06.17	BioSpecifics Technologies Corp. to Present at the Jefferies 2017 Healthcare Conference (PR Newswire)
10.05.17	BioSpecifics Technologies Corp. Reports First Quarter 2017 Financial Results (PR Newswire)
18.04.17	BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids (PR Newswire)
29.03.17	BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference (PR Newswire)
15.03.17	BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
24.01.17	BioSpecifics Technologies Corp. to Present at NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference (PR Newswire)
18.11.16	BSTC Finds New Use For Old Drug, FHCO Gets A Boost, SUPN Put On Notice (RTTNews)
14.06.16	RVNC Wrinkled, MRNS Jolted As Study Fails, BSTC Abuzz, FDA Snubs KMPH (RTTNews)
21.09.15	BioSpecifics Announces First Commercial Sale Of Xiaflex In Japan - Quick Facts (RTTNews)
21.07.15	BMRN Expands Breast Cancer Trial, EXEL's Meteor Shines, HZNP Widens Horizons (RTTNews)
20.07.15	BioSpecifics Announces Approval For XIAFLEX In Japan - Quick Facts (RTTNews)
02.02.15	BioSpecifics Reports EU Approval Of XIAPEX To Treat Peyronie's Disease (RTTNews)
21.10.14	BioSpecifics Tech. Reports FDA Approval Of SBLA For XIAFLEX - Quick Facts (RTTNews)
22.08.14	BioSpecifics Announces Positive Data From Phase 2a Study Of CCH For Cellulite (RTTNews)
11.08.14	MOH Opens Wallet, TNXP On The Move, Court Favors PIP (RTTNews)
23.12.13	BioSpecifics Reports Top-line Data From Phase 2 Trial Of CCH For Canine Lipoma (RTTNews)
13.12.13	BioSpecifics Announces Initiation Of Phase 2b Study Of CCH (RTTNews)
06.12.13	BioSpecifics Tech Says FDA Approved XIAFLEX For Treatment Of Peyronie's Disease (RTTNews)
24.10.13	AGN's Filler Gets FDA Green Light, ADXS, CYTR On Watch, IMMU On The Move (RTTNews)
07.10.13	BioSpecifics Technologies Corp. Announces Data from Multiple Studies of XIAFLEX for Treatment of Dupuytren's Contracture Presented at American Society for Surgery of the Hand 2013 (PR Newswire)
19.09.13	BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference (PR Newswire)
01.08.13	BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2013 Financial Results on Thursday, August 8, 2013 (PR Newswire)
23.07.13	BioSpecifics Technologies Corp. Announces Data from Collaborative Uterine Fibroid Study Presented at 2013 Society for the Study of Reproduction Annual Meeting (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.37	2.88 %	K V
Part Grp Hldg	1’330.00	2.39 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’941.00	1.52 %	K V
Novartis	91.64	0.75 %	K V
Geberit	502.80	-0.59 %	K V
CieFinRichemont	139.55	-0.99 %	K V
Swiss Re	133.25	-1.15 %	K V
Zurich Insur Gr	540.00	-1.32 %	K V
Kuehne+Nagel Int	203.00	-2.12 %	K V

Nachrichten zu Biospecifics Technologies Corp

Aktien Top/Flop

Meistgelesene Nachrichten